Exchange of views on the structural difficulties of small and medium-sized enterprises (SMEs) in the antibiotics sector in accessing finance to innovate and commercialise, and how EU instruments can better support them. (Lobbyradar DE, 2026)
Daten unter CC-BY-SA 4.0; Quellen siehe Detailseite.